Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7594 | 1269 | 26.1 | 55% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1052 | 9585 | CARDIOTOXICITY//ANTHRACYCLINES//DOXORUBICIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MODIFIED ANTIBIOT | Address | 27 | 74% | 2% | 20 |
2 | IDARUBICINOL | Author keyword | 23 | 79% | 1% | 15 |
3 | IDARUBICIN | Author keyword | 20 | 23% | 6% | 76 |
4 | PIRARUBICIN | Author keyword | 9 | 27% | 2% | 28 |
5 | DOXORUBICINOL | Author keyword | 7 | 38% | 1% | 15 |
6 | THP ADRIAMYCIN | Author keyword | 6 | 80% | 0% | 4 |
7 | ORAL IDARUBICIN | Author keyword | 6 | 71% | 0% | 5 |
8 | HOSP PHARM YAMASHIMA KU | Address | 6 | 100% | 0% | 4 |
9 | DAUNORUBICINOL | Author keyword | 4 | 50% | 0% | 6 |
10 | IODODOXORUBICIN | Author keyword | 3 | 57% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IDARUBICINOL | 23 | 79% | 1% | 15 | Search IDARUBICINOL | Search IDARUBICINOL |
2 | IDARUBICIN | 20 | 23% | 6% | 76 | Search IDARUBICIN | Search IDARUBICIN |
3 | PIRARUBICIN | 9 | 27% | 2% | 28 | Search PIRARUBICIN | Search PIRARUBICIN |
4 | DOXORUBICINOL | 7 | 38% | 1% | 15 | Search DOXORUBICINOL | Search DOXORUBICINOL |
5 | THP ADRIAMYCIN | 6 | 80% | 0% | 4 | Search THP+ADRIAMYCIN | Search THP+ADRIAMYCIN |
6 | ORAL IDARUBICIN | 6 | 71% | 0% | 5 | Search ORAL+IDARUBICIN | Search ORAL+IDARUBICIN |
7 | DAUNORUBICINOL | 4 | 50% | 0% | 6 | Search DAUNORUBICINOL | Search DAUNORUBICINOL |
8 | IODODOXORUBICIN | 3 | 57% | 0% | 4 | Search IODODOXORUBICIN | Search IODODOXORUBICIN |
9 | EPIRUBICINOL | 3 | 100% | 0% | 3 | Search EPIRUBICINOL | Search EPIRUBICINOL |
10 | N L LEUCYL DOXORUBICIN | 3 | 100% | 0% | 3 | Search N+L+LEUCYL+DOXORUBICIN | Search N+L+LEUCYL+DOXORUBICIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 4 DEMETHOXYDAUNORUBICIN | 28 | 55% | 3% | 36 |
2 | 4 O TETRAHYDROPYRANYLADRIAMYCIN | 17 | 59% | 1% | 19 |
3 | 4 DEMETHOXYDAUNORUBICIN IDARUBICIN | 12 | 52% | 1% | 16 |
4 | ANTHRACYCLINES | 11 | 11% | 7% | 94 |
5 | THP ADRIAMYCIN | 11 | 100% | 0% | 6 |
6 | 4 EPIDOXORUBICIN | 6 | 41% | 1% | 11 |
7 | 4 DEMETHOXY 3 DEAMINO 3 AZIRIDINYL 4 METHYLSULFONYL DAUNORUBICIN PNU 159548 | 6 | 100% | 0% | 4 |
8 | RAT GLIOBLASTOMA CELLS | 5 | 60% | 0% | 6 |
9 | ANTHRACYCLINE ANALOGS | 4 | 47% | 1% | 7 |
10 | DIFFERENT DOSE LEVELS | 4 | 47% | 1% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
IDARUBICIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN THE CHEMOTHERAPY OF CANCER | 1991 | 70 | 131 | 77% |
Quantitative liquid chromatographic analysis of anthracyclines in biological fluids | 2011 | 3 | 95 | 77% |
CLINICAL PHARMACOKINETICS OF EPIRUBICIN | 1994 | 36 | 52 | 87% |
CLINICAL PHARMACOKINETICS OF DOXORUBICIN | 1988 | 195 | 89 | 37% |
Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs | 2002 | 84 | 47 | 32% |
New oral drugs in older patients: a review of idarubicin in elderly patients | 2004 | 14 | 67 | 78% |
PHARMACOKINETICS AND METABOLISM OF ANTHRACYCLINES | 1993 | 86 | 153 | 47% |
ANTHRACYCLINE ANALOGS - THE PAST, PRESENT, AND FUTURE | 1986 | 144 | 62 | 68% |
IDARUBICIN IN THE TREATMENT OF ACUTE LEUKEMIAS - AN OVERVIEW OF PRECLINICAL AND CLINICAL-STUDIES | 1990 | 33 | 21 | 100% |
CLINICAL PHARMACOKINETICS OF IDARUBICIN | 1993 | 33 | 50 | 82% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MODIFIED ANTIBIOT | 27 | 74% | 1.6% | 20 |
2 | HOSP PHARM YAMASHIMA KU | 6 | 100% | 0.3% | 4 |
3 | DAR ES SALAAM UNIV EDUC | 2 | 67% | 0.2% | 2 |
4 | SURG UNIT SEMEIOT CHIRURG | 2 | 67% | 0.2% | 2 |
5 | 5 MISASAGINAKAUCHI CHO | 1 | 100% | 0.2% | 2 |
6 | IRCCS PAVIA | 1 | 40% | 0.2% | 2 |
7 | UNIT ONCOL 2 | 1 | 40% | 0.2% | 2 |
8 | 332 N LAUDERDALEPOB 318 | 1 | 50% | 0.1% | 1 |
9 | CATHARIJNESINGEL 60 | 1 | 50% | 0.1% | 1 |
10 | ENVIRONM TOXICOL MEASUREMENTS | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000240851 | METHOXYMORPHOLINO DOXORUBICIN//AD 198//METHOXYMORPHOLINYL DOXORUBICIN |
2 | 0.0000238393 | MENOGARIL//ACLARUBICIN//BIOSYNTHESIS AND PROCESSING |
3 | 0.0000132554 | CARDIOTOXICITY//DEXRAZOXANE//DOXORUBICIN |
4 | 0.0000079235 | PIROXANTRONE//MITOXANTRONE//PIXANTRONE |
5 | 0.0000077551 | AN 9//SABARUBICIN//AN 7 |
6 | 0.0000072916 | ERYTHROID GENES//THERMOBIOL//ACLARUBICIN |
7 | 0.0000068715 | ETOPOSIDE PHOSPHATE//ETOPOSIDE//ORAL ETOPOSIDE |
8 | 0.0000063128 | 2 3 4 DIARYL 5 OXO 1 2 4 TRIAZINE 6 YLIDENEACETATES//3 4 DIARYL 1 2 4 TRIAZOLO 5 CARBOXYLATES//ADEUOVIRUS |
9 | 0.0000055208 | ANTHRACYCLINONE//NISHI OHNUMA//441 NISHI OHNUMA |
10 | 0.0000054699 | TRIMELAMOL//HEXAMETHYLMELAMINE//DEHYDROEMETINE |